| 1 |
15608477 | Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. | 2005 Jan-Feb |
1 |
| 2 |
12494145 | [Gender differences in the state of the system of hemostasis in patients with ischemic heart disease]. | 2002 |
1 |
| 3 |
9217177 | Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. | 1997 Jun |
1 |
| 4 |
7878631 | Antithrombin III: associations with age, race, sex and cardiovascular disease risk factors. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. | 1994 Oct |
1 |
| 5 |
1649042 | Hepatocarcinoma in cirrhosis. Is antithrombin III a neoplastic marker? | 1991 Jul |
1 |
| 6 |
2079995 | Effect of corticosteroids on some hemostatic parameters in children with minimal change nephrotic syndrome. | 1990 |
1 |
| 7 |
6612689 | The effect of variable fat diets and cholesterol-lowering drugs on Antithrombin III levels in hyperlipoproteinemic and normal subjects. | 1983 Jun 15 |
1 |
| 8 |
7101236 | Inhibition of thrombin-neutralizing activity of antithrombin III by steroid hormones. | 1982 Apr 30 |
1 |
| 9 |
7226527 | Increased plasma antithrombin III level in hyperlipidemic subjects. | 1981 Mar 5 |
1 |